Go Pro
NASDAQ:NEOG

Neogen (NEOG) Stock Price, News & Analysis

Neogen logo
$11.49 +0.09 (+0.79%)
Closing price 04:00 PM Eastern
Extended Trading
$11.78 +0.29 (+2.48%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Neogen Stock (NASDAQ:NEOG)

Advanced

Key Stats

Today's Range
$11.35
$11.70
50-Day Range
$8.81
$12.04
52-Week Range
$4.90
$12.85
Volume
2.29 million shs
Average Volume
2.33 million shs
Market Capitalization
$2.51 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.67
Consensus Rating
Hold

Company Overview

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E. coli, as well as methods for mycotoxin and allergen detection. These offerings are complemented by software, instrumentation and training services that help customers maintain regulatory compliance and optimize their quality control processes. The company regularly invests in research and development to expand its testing capabilities and to address emerging contaminants in the food supply chain.

Beyond food testing, Neogen serves the animal safety market with an array of products for livestock and companion animals. Its animal safety segment provides medicated and non‐medicated feed additives, premixes, disinfectants and veterinary instruments. These products support animal health and productivity in industries such as dairy, poultry, swine and aquaculture. Neogen also supplies nutritional feed supplements and environmental hygiene solutions that help producers manage disease risk and improve overall herd performance.

Neogen operates through a network of subsidiaries and distribution partners in more than 100 countries across North America, Europe, Asia and Latin America. The company is led by James Herbert, who serves as president and chief executive officer, and emphasizes a commitment to innovation, quality and customer support. By combining proprietary technologies with global reach, Neogen aims to address critical safety challenges in the food and animal health markets.

AI Generated. May Contain Errors.

Neogen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

NEOG MarketRank™: 

Neogen scored higher than 56% of companies evaluated by MarketBeat, and ranked 680th out of 902 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Neogen has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 1 sell rating.

  • Upside/Downside

    The consensus price target for Neogen is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Neogen has only been the subject of 2 research reports in the past 90 days.

  • Read more about Neogen's stock forecast and price target.
  • Earnings Growth

    Earnings for Neogen are expected to grow by 28.00% in the coming year, from $0.25 to $0.32 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Neogen is -383.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Neogen is -383.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Neogen has a PEG Ratio of 4.50. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Neogen has a P/B Ratio of 1.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Neogen's valuation and earnings.
  • Percentage of Shares Shorted

    4.35% of the float of Neogen has been sold short.
  • Short Interest Ratio / Days to Cover

    Neogen has a short interest ratio ("days to cover") of 4.34.
  • Change versus previous month

    Short interest in Neogen has recently decreased by 12.53%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Neogen does not currently pay a dividend.

  • Dividend Growth

    Neogen does not have a long track record of dividend growth.

  • News Sentiment

    Neogen has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Neogen this week, compared to 8 articles on an average week.
  • Search Interest

    9 people have searched for NEOG on MarketBeat in the last 30 days. This is an increase of 800% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Neogen to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Neogen insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,370.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    0.55% of the stock of Neogen is held by insiders.

  • Percentage Held by Institutions

    96.73% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Neogen's insider trading history.
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NEOG Stock News Headlines

Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Neogen (NEOG) Q4 2026 Earnings
See More Headlines

NEOG Stock Analysis - Frequently Asked Questions

Neogen's stock was trading at $6.99 at the beginning of 2026. Since then, NEOG stock has increased by 64.4% and is now trading at $11.49.

Neogen Corporation (NASDAQ:NEOG) announced its quarterly earnings data on Thursday, July, 30th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.03. The company's quarterly revenue was down .1% on a year-over-year basis.
Read the conference call transcript
.

Neogen's stock split on Tuesday, January 2nd 2018.The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were issued to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

Top institutional shareholders of Neogen include BlackRock Inc. (15.33%), Bank of New York Mellon Corp (0.58%), Deutsche Bank AG (0.17%) and Handelsbanken Fonder AB (0.04%). Insiders that own company stock include John Edward Adent, David H Naemura, James C Borel, Douglas Edward Jones, James P Tobin, Amy M Rocklin, Jason Warren Lilly, William T Boehm, Aashima Gupta, John Patrick Moylan and Mikheal Nassif.
View institutional ownership trends
.

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neogen investors own include NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
7/30/2026
Today
8/11/2026
Next Earnings (Estimated)
10/08/2026
Fiscal Year End
5/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:NEOG
CIK
711377
Employees
2,110
Year Founded
1982

Price Target and Rating

High Price Target
$13.00
Low Price Target
$10.00
Potential Upside/Downside
+1.5%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
45.96
P/E Growth
4.5
Net Income
-$7.90 million
Net Margins
-0.91%
Pretax Margin
-1.03%
Return on Equity
2.78%
Return on Assets
1.74%

Debt

Debt-to-Equity Ratio
0.38
Current Ratio
3.82
Quick Ratio
2.91

Sales & Book Value

Annual Sales
$870.40 million
Price / Sales
2.88
Cash Flow
$0.85 per share
Price / Cash Flow
13.52
Book Value
$9.61 per share
Price / Book
1.20

Miscellaneous

Outstanding Shares
218,060,000
Free Float
216,857,000
Market Cap
$2.51 billion
Optionable
Optionable
Beta
1.77

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:NEOG) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners